产品标题 产品货号 产品规格 厂家
Sterile alpha motif domain containing 12 (SAMD12), transcript variant 2 from ORIGENE TECHNOLOGIESLY404050100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 13 (SAMD13), transcript variant 1 from ORIGENE TECHNOLOGIESLY423246100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 3 (SAMD3), transcript variant 1 from ORIGENE TECHNOLOGIESLY422767100 ugORIGENE TECHNOLOGIES
Sterile alpha motif domain containing 8 (SAMD8), transcript variant 1 from ORIGENE TECHNOLOGIESLY433038100 ugORIGENE TECHNOLOGIES
Steroid 5 alpha-reductase 3 (SRD5A3) from ORIGENE TECHNOLOGIESLY411208100 ugORIGENE TECHNOLOGIES
Steroidogenic acute regulatory protein (STAR), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESLY424767100 ugORIGENE TECHNOLOGIES
Steroidogenic acute regulatory protein (STAR), nuclear gene encoding mitochondrial protein, transcript variant 2 from ORIGENE TECHNOLOGIESLY423465100 ugORIGENE TECHNOLOGIES
Steroidogenic acute regulatory protein (STAR), nuclear gene encoding mitochondrial protein, transcript variant 2 from ORIGENE TECHNOLOGIESLY425216100 ugORIGENE TECHNOLOGIES
Steroid receptor RNA activator 1 (SRA1) from ORIGENE TECHNOLOGIESLY422126100 ugORIGENE TECHNOLOGIES
Steroid sulfatase (microsomal), isozyme S (STS) from ORIGENE TECHNOLOGIESLY424769100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 1 from ORIGENE TECHNOLOGIESLY401042100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 3 from ORIGENE TECHNOLOGIESLY422797100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 4 from ORIGENE TECHNOLOGIESLY422798100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 6 from ORIGENE TECHNOLOGIESLY434278100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 7 from ORIGENE TECHNOLOGIESLY434294100 ugORIGENE TECHNOLOGIES
Sterol carrier protein 2 (SCP2), transcript variant 8 from ORIGENE TECHNOLOGIESLY434253100 ugORIGENE TECHNOLOGIES
Sterol-C4-methyl oxidase-like (SC4MOL), transcript variant 2 from ORIGENE TECHNOLOGIESLY422643100 ugORIGENE TECHNOLOGIES
Sterol O-acyltransferase 2 (SOAT2) from ORIGENE TECHNOLOGIESLY418574100 ugORIGENE TECHNOLOGIES
Sterol O-acyltransferase 1 (SOAT1), transcript variant 688113 from ORIGENE TECHNOLOGIESLY418898100 ugORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8028775x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8065125x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS8065135x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS6099755x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Leukemia, lymphocytic, chronic from ORIGENE TECHNOLOGIESCS6246215x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoid hyperplasia of lung from ORIGENE TECHNOLOGIESCS7055765x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoid hyperplasia of lung from ORIGENE TECHNOLOGIESCS7055775x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoid hyperplasia of lung from ORIGENE TECHNOLOGIESCS5188945x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoid hyperplasia of lung from ORIGENE TECHNOLOGIESCS5188955x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, anaplastic large cell from ORIGENE TECHNOLOGIESCS8135325x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, anaplastic large cell from ORIGENE TECHNOLOGIESCS6485015x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7012765x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7036605x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7036615x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7092935x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7092955x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS7092975x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8060625x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8060635x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090175x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090185x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090205x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090235x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090245x5umORIGENE TECHNOLOGIES
Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIESCS8090255x5umORIGENE TECHNOLOGIES
TTC27 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30901610 ugORIGENE TECHNOLOGIES
TTC32 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30933410 ugORIGENE TECHNOLOGIES
TTC33 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30236010 ugORIGENE TECHNOLOGIES
TTC35 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30477010 ugORIGENE TECHNOLOGIES
TTC36 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31853510 ugORIGENE TECHNOLOGIES
TTC38 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30284210 ugORIGENE TECHNOLOGIES
 |< < 649 650 651 652 653 654 655 656 657 > >| 第 657/6274 页